Biotech - Spark Newswire

2 minute read

Twist Bioscience Collaborates With Regeneron For Production Of Genotyping By Sequencing Panel To Enable Diverse Genome-Wide Screening; Terms Not Disclosed

June 14, 8:05 AM

Population Genetics Sequencing Panel Incorporates Global Genetic Variations for Superior Study of Disease and Target Discovery -- Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed

REGN

1 minute read

Why Is Enochian BioSciences (ENOB) Stock Surging Today?

By Vandana Singh

June 14, 7:57 AM

The FDA has accepted Enochian BioSciences Inc’s (NASDAQ:ENOB) pre-IND (Investigational New Drug) request for a potential functional cure or treatment of…

ENOB

1 minute read

Why Novavax Stock Is Moving Today

By Henry Khederian

June 14, 7:55 AM

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 9.8% at $230.25 Monday morning after the company announced positive Phase 3 trial results for its COVID-19 vaccine.

NVAX

1 minute read

iTeos Therapeutics Stock Surges On $2.1B Development Pact For EOS-448 With GSK

By Vandana Singh

June 14, 7:47 AM

iTeos Therapeutics (NASDAQ:ITOS) and GlaxoSmithKline plc (NYSE:GSK) have agreed to co-develop and co-commercialize EOS-448, an anti-TIGIT monoclonal antibody. Under the terms of…

GSK

1 minute read

Johnson & Johnson Building Case With New Patient Survival Data For Darzalex In Multiple Myeloma

By Vandana Singh

June 14, 7:35 AM

Janssen Pharmaceutical, a unit of Johnson & Johnson (NYSE:JNJ), announced overall survival (OS) results from the Phase 3 MAIA study evaluating the…

BMY

1 minute read

Ascendis Pharma’s TransCon hGH FDA Review Pushed Backed By Three Months

By Vandana Singh

June 14, 7:23 AM

The FDA has extended the ongoing review of the marketing application of Ascendis Pharma A/S’s (NASDAQ:ASND) TransCon hGH (lonapegsomatropin) for the treatment…

ASND

1 minute read

Sorrento, Mayo Clinic Ink Research Pact For Ipilimumab-Delivering Sofusa In Melanoma Patients

By Vandana Singh

June 14, 7:20 AM

Sorrento Therapeutics Inc (NASDAQ:SRNE) entered into a research collaboration agreement with Mayo Clinic to conduct human clinical proof of concept studies…

SRNE

2 minute read

AIM ImmunoTech Highlights Ampligen Featured in Peer-Reviewed Journal Cancers As A Potential Therapy For Cancer Patients With SARS-CoV-2

By Bill Haddad

June 14, 7:18 AM

AIM ImmunoTech Inc. (NYSE:AIM) today announced that its drug Ampligen has been featured in a publication containing state-of-the-art methodologies in the peer-reviewed medical journal Cancers as a potential

AIM

1 minute read

Avenue Therapeutics Pain Management Treatment Rejected By FDA Again; Shares Drop

By Vandana Singh

June 14, 7:18 AM

Avenue Therapeutics Inc (NASDAQ:ATXI) has received a second Complete Response Letter from the FDA regarding its marketing application seeking approval for…

ATXI

1 minute read

Sorrento Therapeutics Starts Large Efficacy Trial For Intranasal COVID-19 Antibody In UK

By Vandana Singh

June 14, 7:15 AM

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) signed off Sorrento Therapeutics Inc’s (NASDAQ:SRNE) Phase 2 trial evaluating COVI-DROPS in…

SRNE